Enseval Putra Megatrading Tbk - Asset Resilience Ratio
Enseval Putra Megatrading Tbk (EPMT) has an Asset Resilience Ratio of 1.54% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read EPMT total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2024)
This chart shows how Enseval Putra Megatrading Tbk's Asset Resilience Ratio has changed over time. See EPMT total equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Enseval Putra Megatrading Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Enseval Putra Megatrading Tbk.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 0% |
| Short-term Investments | Rp188.19 Billion | 1.54% |
| Total Liquid Assets | Rp188.19 Billion | 1.54% |
Asset Resilience Insights
- Limited Liquidity: Enseval Putra Megatrading Tbk maintains only 1.54% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Enseval Putra Megatrading Tbk Industry Peers by Asset Resilience Ratio
Compare Enseval Putra Megatrading Tbk's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368 |
Medical Distribution | 1.77% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Cyclopharm Ltd
AU:CYC |
Medical Distribution | 1.98% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 4.44% |
Annual Asset Resilience Ratio for Enseval Putra Megatrading Tbk (2000–2024)
The table below shows the annual Asset Resilience Ratio data for Enseval Putra Megatrading Tbk.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 3.83% | Rp440.25 Billion ≈ $25.80 Million |
Rp11.49 Trillion ≈ $673.12 Million |
+1.14pp |
| 2023-12-31 | 2.69% | Rp294.57 Billion ≈ $17.26 Million |
Rp10.96 Trillion ≈ $641.97 Million |
-2.29pp |
| 2022-12-31 | 4.98% | Rp518.17 Billion ≈ $30.36 Million |
Rp10.40 Trillion ≈ $609.54 Million |
+2.48pp |
| 2021-12-31 | 2.50% | Rp243.46 Billion ≈ $14.27 Million |
Rp9.73 Trillion ≈ $570.13 Million |
+0.63pp |
| 2020-12-31 | 1.87% | Rp172.47 Billion ≈ $10.11 Million |
Rp9.21 Trillion ≈ $539.77 Million |
-0.20pp |
| 2019-12-31 | 2.07% | Rp180.60 Billion ≈ $10.58 Million |
Rp8.70 Trillion ≈ $510.08 Million |
+0.10pp |
| 2018-12-31 | 1.97% | Rp164.32 Billion ≈ $9.63 Million |
Rp8.32 Trillion ≈ $487.69 Million |
-0.15pp |
| 2017-12-31 | 2.13% | Rp157.82 Billion ≈ $9.25 Million |
Rp7.43 Trillion ≈ $435.12 Million |
+0.07pp |
| 2016-12-31 | 2.06% | Rp145.74 Billion ≈ $8.54 Million |
Rp7.09 Trillion ≈ $415.29 Million |
+0.09pp |
| 2015-12-31 | 1.97% | Rp132.81 Billion ≈ $7.78 Million |
Rp6.75 Trillion ≈ $395.40 Million |
+1.02pp |
| 2014-12-31 | 0.95% | Rp58.69 Billion ≈ $3.44 Million |
Rp6.19 Trillion ≈ $362.75 Million |
+0.41pp |
| 2013-12-31 | 0.53% | Rp29.48 Billion ≈ $1.73 Million |
Rp5.53 Trillion ≈ $323.92 Million |
-0.42pp |
| 2011-12-31 | 0.95% | Rp41.45 Billion ≈ $2.43 Million |
Rp4.37 Trillion ≈ $256.11 Million |
+0.93pp |
| 2010-12-31 | 0.02% | Rp515.21 Million ≈ $30.19K |
Rp3.25 Trillion ≈ $190.72 Million |
-0.05pp |
| 2006-12-31 | 0.07% | Rp1.26 Billion ≈ $73.58K |
Rp1.81 Trillion ≈ $106.34 Million |
-19.54pp |
| 2005-12-31 | 19.61% | Rp364.48 Billion ≈ $21.36 Million |
Rp1.86 Trillion ≈ $108.91 Million |
-2.13pp |
| 2004-12-31 | 21.74% | Rp359.60 Billion ≈ $21.07 Million |
Rp1.65 Trillion ≈ $96.92 Million |
-9.57pp |
| 2003-12-31 | 31.32% | Rp413.84 Billion ≈ $24.25 Million |
Rp1.32 Trillion ≈ $77.43 Million |
+11.64pp |
| 2002-12-31 | 19.68% | Rp216.17 Billion ≈ $12.67 Million |
Rp1.10 Trillion ≈ $64.36 Million |
+5.77pp |
| 2001-12-31 | 13.91% | Rp124.69 Billion ≈ $7.31 Million |
Rp896.59 Billion ≈ $52.54 Million |
+5.09pp |
| 2000-12-31 | 8.81% | Rp72.25 Billion ≈ $4.23 Million |
Rp819.62 Billion ≈ $48.03 Million |
-- |
About Enseval Putra Megatrading Tbk
PT Enseval Putera Megatrading Tbk., together with its subsidiaries, engages in the distribution and supply of pharmaceutical products, consumer products, medical equipment, cosmetics, and other products in Indonesia. The company operates through Pharmaceutical, Consumer Products, and Others segments. It also trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical… Read more